Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This trial will assess whether long-acting levodopa taken at night improves obstructive sleep
apnea (OSA) in patients with Parkinson's disease (PD), as compared with placebo.
Phase:
Phase 4
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre